Osteosarcoma Community News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Osteosarcoma Community. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Osteosarcoma Community Today - Breaking & Trending Today

OS Therapies Announces Nationwide Open Enrollment of Remaining 36 to 42 Patients in Phase IIb Trial of OST-HER2 (Listeria monocytogenes) in Recurred, Resected Osteosarcoma

Published: January 27, 2022

/PRNewswire/ -- OS Therapies, a research and clinical-stage biopharmaceutical company announced today that the Data Safety & Monitoring Committee (DSMC)...

Source: prnewswire.com

Related Topics:

United KingdomUnited StatesMiriam CohenJohns Hopkins BaltimoreData Safety Monitoring CommitteeJude Children Research HospitalKaiser Permanente Downey Medical CenterOsteosarcoma CommunityHackensack University Medical CenterOs Therapies IncUt Southwestern Children Medical CenterData SafetyMonitoring CommitteeResected OsteosarcomaOsteosarcoma CollaborativeOverall SurvivalRare Disease DesignationOrphan DesignationsBreak Through DesignationOs Therapies

OS Therapies Announces Dosing of First Patient in a Phase IIb Trial of OST-HER2 (Listeria monocytogenes) in Recurred, Resected Osteosarcoma

Published: October 22, 2021

/PRNewswire/ -- OS Therapies, a research and clinical-stage biopharmaceutical company announced today the dosing of the "First Patient In" for its lead...

Source: prnewswire.com

Related Topics:

United KingdomUnited StatesNew ZealandDouglass HawkinsRobert PetitDamon ReedNational Clinical Trials NetworkUniversity Of WashingtonChildren Oncology GroupOsteosarcoma CommunityMoffitt Cancer CenterOs Therapies IncOrphan DesignationOverall SurvivalDisease ProgressionOncology GroupSeattle ChildrenInstitutional EnthusiasmPrinciple InvestigatorMoffitt CancerClinical Trials NetworkNorth AmericaOrphan DesignationsRare Disease DesignationBreak Through Designation